Skip to Content

Why Do I See Halos After Cataract Surgery? The Science of Dysphotopsia, IOL Optics & Night Vision 2026

Halos & Glare After Cataract Surgery: Science of Dysphotopsia & IOL Optics 2026 | Agaaz Ophthalmics

Intraocular Solutions · Science Series

Why do I see halos
after cataract surgery?
The physics of dysphotopsia.

A complete science guide to halos, glare, and starbursts after IOL implantation — from diffractive optics and pupil dynamics to neuroadaptation timelines. Evidence from 12 peer-reviewed studies.

20%

patients experience
negative dysphotopsia

90%

halo reduction
within 6 months

12

peer-reviewed
citations

22 min

reading time

Section 01 — Definition

What is dysphotopsia?
The two types explained.

Dysphotopsia is the umbrella term for unwanted visual phenomena — rings, arcs, shadows, and flares — that appear after cataract surgery. It is one of the most common complaints following intraocular lens implantation, yet remains poorly understood by most patients and under-explained by most clinical resources.

The term derives from the Greek dys- (abnormal) + phos (light) + opsis (vision). It encompasses two distinct and mechanistically opposite phenomena that are frequently confused with one another.

Positive Dysphotopsia — the science in 134 words

Positive dysphotopsia refers to the perception of excess light in the visual field after IOL implantation. It manifests as halos (luminous rings surrounding point light sources), glare (diffuse brightness that reduces contrast), starbursts (radial spokes emanating from lights), and arcs (crescent-shaped light bands). These phenomena arise when light passes through the peripheral zones of the IOL optic — the edge, transition zones between diffractive rings, or the interface between the anterior capsule and the IOL — and is refracted or diffracted onto an unintended location on the retina, creating an out-of-focus secondary image superimposed on the primary image. Positive dysphotopsia is most noticeable in dim-light or dark conditions, when pupil dilation brings more of the IOL's peripheral optical elements within the functional aperture. Sources: Henderson BA & Yi DH. J Cataract Refract Surg. 2011; PMC 2021.

Negative Dysphotopsia — the temporal shadow

Negative dysphotopsia is the perception of a dark arc or shadow in the temporal peripheral visual field after cataract surgery — the opposite of halos. Affecting up to 20% of patients subjectively in published series, it presents as a crescent-shaped dark band typically in the temporal periphery of one or both eyes. The exact mechanism remains debated, but the leading hypothesis is that the sharp square edge of modern IOL optics creates a zone of total internal reflection, preventing peripheral light rays from reaching the nasal retina while the optic edge itself creates a shadow. Piggyback IOL implantation or reverse optic capture can resolve refractory cases. Unlike positive dysphotopsia, neuroadaptation is less reliable for the negative form — approximately 10–15% of affected patients continue to notice it beyond 12 months. Sources: Holladay JT et al. J Cataract Refract Surg. 2012; Vámosi P et al. PMC 2021.

💡
Halos
Luminous rings around point light sources. Caused by out-of-focus diffractive rings projecting secondary images onto the retina. Worst in dim conditions when the pupil dilates beyond the central optic zone.
Starbursts
Radial spokes around lights. Often caused by corneal higher-order aberrations or by the radial symmetric structure of diffractive rings, producing a Fourier diffraction pattern visible as spike-like rays.
🌑
Negative Shadow
A dark temporal arc caused by the IOL's square edge blocking peripheral light via total internal reflection. Does not improve reliably with neuroadaptation. More common with high-refractive-index hydrophobic IOLs.
🌫️
Glare
Diffuse reduction in contrast and brightness uniformity. Caused by light scattering at IOL surfaces, posterior capsule interface, or within the IOL material itself (especially with glistening artefacts in hydrophobic acrylics).

Section 02 — Optics Science

The physics of diffractive optics
How IOL design creates halos.

To understand dysphotopsia, you need to understand diffraction — the bending of light waves around obstacles and through apertures. It is the same phenomenon that creates rainbow patterns on CDs and the coloured rings around street lights on foggy nights.

Diffractive rings: splitting light between focal points

Diffractive IOLs use a series of microscopic concentric steps — called diffractive rings or echelettes — etched into the anterior or posterior surface of the lens optic. Each step is typically 0.6–2.0 µm in height. When light strikes these steps, it is split into multiple wavefronts that interfere constructively at specific focal distances determined by the ring spacing (analogous to a grating equation: mλ = d sinθ, where m is the diffraction order, λ is wavelength, and d is the grating period).

A trifocal IOL distributes incoming light energy across three focal orders: 0th order (distance), 1st order (near), and a half-integer intermediate order achieved through a modified ring profile. Energy not directed to any focal point becomes diffuse stray light — forming the basis of halos. The energy distribution is typically: 40% distance / 20% intermediate / 35% near / ~5% stray.

Key insight: The halo you see is literally the out-of-focus image of a light source formed by the diffractive ring system. When you look at a streetlight with a trifocal IOL, your retina receives three superimposed images — one sharp (distance focal point) and two progressively defocused rings (near and intermediate focal points, defocused at distance). The rings of energy from these defocused images are what you perceive as a halo.

Why halos are circular

The concentric circular symmetry of diffractive rings produces circular diffraction patterns by Huygens' principle — every point on a wavefront acts as a source of secondary spherical wavelets. The constructive interference of wavelets from the concentric ring system produces a circular (Airy-disk-like) intensity pattern centred on the point source. The radius of the halo in your visual field corresponds to the angular separation between the primary focal image and the first defocused order — typically 3–5 degrees in standard trifocal designs, appearing as a ring of approximately 30–40 cm diameter at a viewing distance of 6 metres.

Clinical note: EDOF IOLs using non-diffractive mechanisms (continuous refractive power variation, spherical aberration engineering, or chromatic aberration manipulation) do not produce the sharp-ring halo pattern of diffractive designs. They may produce a softer glow around lights, but the intensity is typically rated as "trace" or "mild" on validated questionnaires vs. "moderate" for diffractive trifocals.
Interactive Dysphotopsia Simulator
Select an IOL type to simulate the visual experience of night-time halos and glare. Illustrative only — individual results vary.
Warm street light White light source Halo / diffraction ring

The role of the pupil: why halos worsen at night

The central optical zone of most diffractive IOLs is 3.0–4.5 mm in diameter. In photopic (bright) conditions the pupil constricts to 2–3 mm — entirely within this central zone, so the diffractive rings at the periphery are masked by the iris. In scotopic (dark) conditions the pupil dilates to 6–8 mm in younger adults, 5–6 mm in older adults, exposing the peripheral diffractive echelettes.

Each additional ring exposed contributes additional stray-light energy to the halo, increasing its apparent brightness. This is why patients universally report that "halos are much worse at night" — it is a direct consequence of pupil physics, not an indication that vision is damaged or worsening.

Practical implication: Patients with naturally large scotopic pupils (>6 mm) are at significantly higher risk of bothersome dysphotopsia with diffractive premium IOLs. Pre-operative pupillometry under scotopic conditions is an important but often overlooked part of the IOL selection workup. Patients with pupil diameter >6 mm under dim-light conditions should be counselled carefully before diffractive trifocal implantation.

Section 03 — Material Science

Material and edge design:
The other source of dysphotopsia.

Not all dysphotopsia comes from diffractive optics. IOL material, refractive index, and edge geometry independently influence photic phenomena — even in monofocal IOLs that carry no diffractive profile whatsoever.

Hydrophobic vs hydrophilic acrylic: the index-of-refraction effect

Modern IOLs are manufactured from two primary acrylic formulations:

Water Content0–4% — very low water uptake; foldable for micro-incision delivery
Refractive Index1.47–1.55 — high; enables thinner optic at same power
Dysphotopsia RiskHigher — high refractive index increases internal reflection at sharp edges, increasing positive dysphotopsia intensity. Negative dysphotopsia more common vs hydrophilic.
PCO RiskLow — square-edge design effectively blocks lens epithelial cell migration. Gold standard for posterior capsule opacification prevention.
ExamplesAcrySof (Alcon), CT ASPHINA (Zeiss), SN60WF platform. Agaaz OP-VIEW AS, OP-FOLD AS.
Glistening RiskModerate — micro-vacuole formation within acrylic matrix can increase light scattering over time in some hydrophobic materials; newer generation materials mitigate this significantly.
Water Content18–38% — high water content; soft, very foldable, minimal corneal trauma on delivery
Refractive Index1.43–1.46 — lower; requires slightly thicker optic for equivalent power
Dysphotopsia RiskLower — rounded or bevelled edge combined with lower refractive index reduces internal reflection, producing fewer positive dysphotopsia symptoms. Less negative dysphotopsia than hydrophobic designs.
PCO RiskHigher — softer haptics and rounded edges provide less effective barrier to lens epithelial cell migration. Square-edge hydrophilic IOLs now available to partially address this.
Examplesi-Nera (Agaaz), Rayner (Rayner Intraocular Lenses), Precizon (Ophtec), PC-233-14 series.
Glistening RiskCalcification risk in specific contexts (silicone oil eyes, anterior segment inflammation). Not relevant for routine cataract cases.
Water Content0% — rigid material; requires 5.5–7mm incision; rarely used in modern phacoemulsification
Refractive Index1.49 — intermediate
Dysphotopsia RiskLow to moderate — PMMA is optically very pure with minimal internal scatter; older round-edge designs produced few photic phenomena
PCO RiskHigh — original PMMA designs with round edges had very high PCO rates. Relevant only for ECCE or second-world settings where phaco is unavailable.
ExamplesLegacy IOLs; still used in some low-resource settings due to cost.
Glistening RiskNone — PMMA does not develop glistenings.

The square-edge dilemma: PCO prevention vs. dysphotopsia

The introduction of sharp, square posterior optic edges in the late 1990s was one of the most effective interventions in cataract surgery — reducing posterior capsule opacification (PCO) rates from 30–50% at 5 years (round edge) to under 5% (square edge) by physically blocking lens epithelial cell migration along the posterior capsule. However, this same optical geometry is the primary cause of positive and negative dysphotopsia in monofocal IOLs.

The mechanism: light rays entering the eye at oblique angles strike the sharp posterior edge of the optic and undergo total internal reflection (TIR) — because the angle of incidence exceeds the critical angle for the acrylic/aqueous interface, which depends on the refractive index. This reflected light is then directed towards the retina as an arc or ring of stray illumination. The higher the refractive index of the IOL material, the higher the proportion of incident angles that exceed the critical angle, and the more pronounced the dysphotopsia.

The design trade-off: A rounded edge reduces total internal reflection and dysphotopsia but increases PCO risk. A square edge prevents PCO but may worsen positive and negative dysphotopsia. Modern IOL designs address this through edge undulation — a micro-scale sinusoidal perturbation of the square-edge profile that disperses the reflected rays over a wider area of retina, reducing their perceived intensity without surrendering the PCO barrier effect.

Section 04 — Clinical Evidence

Dysphotopsia rates
by IOL type: the evidence.

Published clinical data on photic phenomena across IOL categories. Data aggregated from peer-reviewed systematic reviews, randomised controlled trials, and the 2026 three-year mix-and-match study (PMC 12928826).

Halo and glare severity is typically measured on validated questionnaires: the Visual Disturbance Questionnaire (VDQ), the Patient Reported Spectacle Independence (PRSI), or the Ocular Surface Disease Index adapted for photic phenomena. Scores below represent the proportion of patients reporting moderate-to-severe photic phenomena at 6 months post-operatively.

Standard Monofocal IOL3–8%
Enhanced Monofocal (monofokal plus)8–15%
Non-Diffractive EDOF (refractive)10–18%
Diffractive EDOF (echelette profile)22–35%
Diffractive Trifocal IOL40–65%
Important context: These rates measure incidence of moderate-to-severe photic phenomena, not dissatisfaction. Patient satisfaction with trifocal IOLs remains very high (>90% would choose the same lens again) despite higher dysphotopsia rates — because spectacle independence offsets the inconvenience of halos for most patients. The critical factor is appropriate patient selection and pre-operative counselling.

The 2026 mix-and-match evidence

A landmark three-year follow-up study (Frontiers in Medicine, PMC 12928826, 2026) evaluated two bilateral mix-and-match strategies:

  • Arm A: Enhanced monofocal (dominant eye) + diffractive trifocal (non-dominant eye)
  • Arm B: Enhanced monofocal (dominant eye) + trifocal EDOF (non-dominant eye)

Both strategies showed significantly lower photic phenomena than bilateral trifocal implantation, while preserving spectacle independence for distance and intermediate vision. The EDOF arm (Arm B) showed marginally fewer halos at 3 years. The study conclusion: mix-and-match implantation combining a low-dysphotopsia lens in the dominant eye with a premium presbyopia-correcting IOL in the non-dominant eye represents the optimal balance between optical quality and near independence.

IOL Category Spectacle Indep. (Distance) Spectacle Indep. (Near) Halo Rate (Mod–Sev) Neg. Dysphotopsia Risk
Standard Monofocal95–99%5–10%3–8%Moderate
Enhanced Monofocal98%20–35%8–15%Moderate
Non-Diffractive EDOF99%40–60%10–18%Low
Diffractive EDOF99%55–75%22–35%Low–Mod
Diffractive Trifocal99%85–95%40–65%Low
Mix-and-Match (EDOF+Tri)99%75–85%15–25%Low

Section 05 — Neuroscience

Neuroadaptation:
How your brain silences the halos.

One of the most clinically significant phenomena in premium IOL outcomes is neuroadaptation — the brain's progressive suppression of unwanted optical signals below the threshold of conscious awareness. Understanding this process helps explain why halos that are distressing at 2 weeks post-surgery are barely noticeable at 6 months.

What is neuroadaptation after IOL implantation?

Neuroadaptation is the process by which the visual cortex progressively learns to suppress or deprioritise consistent, non-informative visual signals — including the halos and glare produced by premium intraocular lenses. The mechanism involves cortical plasticity: the primary visual cortex (V1) and higher visual areas reduce synaptic weighting of the predictable, spatially regular halo pattern because it carries no new information. This is the same neural process underlying spectacle adaptation (initially blurry through new glasses that quickly become normal) and lens accommodation adaptation in contact lens wearers. Active visual engagement — reading, driving, and screen use — accelerates neuroadaptation by providing the cortex with abundant contrast-rich stimuli that compete with the halo signal. Studies show that patients who actively use near-vision tasks during the first month adapt 2–3 months faster than patients who avoid near tasks due to fear of the halos. Sources: Braga-Mele R et al. J Cataract Refract Surg. 2015; Packer M. Curr Opin Ophthalmol. 2019.

The neuroadaptation timeline

Week 1–2
Peak symptom awareness
Halos and glare are most noticeable. The visual cortex has not yet established suppression patterns. Night driving may feel challenging. This is the highest-anxiety period for patients — realistic pre-operative counselling is essential to prevent unnecessary concern.
Week 3–6
Initial suppression begins
The cortex begins building suppression patterns. Most patients notice halos still present but "less alarming." The refraction stabilises in this window. Glasses correction for residual refractive error (if needed) should be prescribed at 4–6 weeks.
Month 2–4
Rapid adaptation
Most patients experience the steepest improvement in symptom scores. In published studies, 60–70% of initially symptomatic patients are at "mild" or "none" by month 3. Bilateral implantation, typically performed 2–4 weeks after the first eye, triggers a second adaptation wave.
Month 6–12
Plateau — approximately 90% adapted
Final neuroadaptation state reached for most patients. Studies report 85–92% of trifocal IOL patients rate halos as "mild" or "absent" at 12 months. The remaining 8–15% continue to report moderate symptoms — these are candidates for photochromic tints, pupil-modulating drops, or in refractory cases, IOL exchange.
Beyond 12 Months
Stable state
Vision quality is now stable. Patients who adapted well maintain their neuroadaptation indefinitely. Long-term studies (3–5 years) show no degradation in optical quality scores for premium diffractive IOLs from a materials perspective, provided the posterior capsule remains clear and no glistenings develop.

Factors that predict faster neuroadaptation

FactorEffect on Adaptation SpeedClinical Action
Bilateral implantation (vs unilateral)2–3× fasterSchedule second eye 2–4 weeks after first
Active near-vision use post-opAccelerates by 4–8 weeksEncourage reading within comfort level
Pre-operative positive photophobiaSlower (2–3 months longer)Screen with photophobia questionnaire
Large scotopic pupil (>6 mm)Slower; may not fully adaptPre-op pupillometry; consider EDOF
Younger patient age (<60)Faster cortical plasticityReassure younger patients
Prior spectacle or contact lens experienceFaster — cortex trainedPositive predictor for IOL adaptation
Residual refractive error (uncorrected)Significantly slowerCorrect residual error early; consider LASIK touch-up

Section 06 — IOL Selection

Choosing the right
intraocular solution:
A framework for surgeons & patients.

IOL selection is not a product decision — it is a personalised optical prescription informed by anatomy, lifestyle, scotopic pupil dynamics, prior visual demands, and realistic outcome expectations. The term intraocular solution captures this better than "IOL choice": you are selecting a complete optical system that will serve the patient for life.

How to choose an IOL to minimise dysphotopsia

The evidence-based approach to IOL selection for minimal dysphotopsia prioritises four assessments. First, measure the scotopic pupil diameter: patients with >6 mm pupils under dim-light conditions are at high risk of bothersome halos with diffractive trifocal IOLs and should be offered non-diffractive EDOF or enhanced monofocal alternatives. Second, assess photophobia history — patients with existing photosensitivity adapt more slowly and may not fully suppress photic phenomena. Third, evaluate lifestyle priority: spectacle independence at near distances is the main advantage of trifocal IOLs over EDOF; patients who prioritise night driving and low-light quality over reading glasses freedom are better served by EDOF or enhanced monofocal designs. Fourth, consider a mix-and-match strategy — implanting a low-dysphotopsia enhanced monofocal in the dominant eye and a premium presbyopia-correcting IOL in the non-dominant eye — which delivers 2026 evidence-supported best practice for balancing optical quality with near independence. Sources: Cochrane systematic review 2024; PMC 12928826, 2026.

The dysphotopsia risk assessment checklist

Perform before any premium IOL implantation:
☑ Scotopic pupillometry (dim-light pupil diameter)
☑ Photophobia assessment (validated questionnaire or clinical interview)
☑ Night driving frequency and importance
☑ Occupation and near-vision demands (surgery, reading, fine work)
☑ Prior spectacle/contact lens tolerance history
☑ Pre-existing dry eye (impacts image quality independently)
☑ Corneal higher-order aberrations (tomography — high HOA worsens trifocal performance)
☑ Macular status (premium IOLs are contraindicated in significant maculopathy)
☑ Realistic expectations — documented pre-operatively

Section 07 — Agaaz Portfolio

Agaaz Intraocular Solutions:
Designed for the full optical spectrum.

At Agaaz Ophthalmics, we design and manufacture the complete intraocular solution ecosystem — from premium IOL platforms to surgical viscoelastics, corneal dyes, and intracameral pharmacologicals — because the outcome of cataract surgery depends on every element inside the eye, not just the lens.

X-VIZ EDOF Platform
Extended Depth of Focus · Non-Diffractive
Agaaz's premium EDOF platform employing a non-diffractive continuous power variation profile to extend the depth of focus from distance to intermediate. Designed with minimal halo induction — photic phenomena rates comparable to enhanced monofocal designs in clinical evaluation. Hydrophilic aspheric acrylic, square-edge PCO barrier, aberration-free optic profile. Ideal for patients with large scotopic pupils, night-driving professionals, and those prioritising optical clarity over near spectacle independence.
OP-VIEW AS
Hydrophobic Aspheric Monofocal · Square-Edge
Single-piece hydrophobic acrylic aspheric IOL with wavefront-optimised optic profile. The aspheric design corrects average corneal positive spherical aberration, improving contrast sensitivity and intermediate vision quality vs. spherical IOLs — particularly relevant in low-contrast, low-illumination environments where dysphotopsia impact is greatest. Square posterior edge provides PCO barrier. Agaaz's benchmark for monofocal optical quality, trusted by surgeons across 15 countries.
OP-FOLD AS
Foldable Hydrophobic Aspheric · Micro-Incision Ready
Foldable single-piece hydrophobic aspheric IOL for delivery through sub-2.2mm micro-incisions. Aspheric posterior optic surface with aberration-correcting profile (−0.20 µm spherical aberration). Square-edge posterior rim. Ideal for use in combination with PURE-HYAL OVD for maximum corneal endothelial protection and anterior chamber stability. A core component of Agaaz's complete surgical intraocular solutions package.
i-Nera
Hydrophilic Aspheric IOL · Low Dysphotopsia Profile
Hydrophilic acrylic aspheric IOL with a specially designed bevelled posterior edge that reduces total internal reflection — addressing the key mechanism of dysphotopsia in monofocal IOLs — while maintaining PCO resistance through the Agaaz biomechanical edge profile. The lower refractive index of hydrophilic acrylic (1.46 vs 1.52–1.55 hydrophobic) further reduces the proportion of light rays exceeding the critical angle for total internal reflection, translating directly to a lower positive and negative dysphotopsia rate. For patients who have experienced or are at risk of photic phenomena.

Our complete intraocular solutions portfolio also includes PURE-HYAL premium sodium hyaluronate OVD (endothelial protection during phacoemulsification), MOXGUARD intracameral moxifloxacin (endophthalmitis prophylaxis), and OP-BLADE precision microsurgical knives. View the complete Agaaz product portfolio →

Section 08 — FAQ

Frequently asked questions
about dysphotopsia.

Halos after cataract surgery — a form of positive dysphotopsia — are caused by light striking the edge or optical zones of your intraocular lens (IOL). Diffractive multifocal and trifocal IOLs split incoming light across multiple focal points; the out-of-focus rings produce circular halos, especially at night when your pupil dilates beyond the central optical zone. The phenomenon is greatest in low-light conditions because the dilated pupil exposes more of the IOL's peripheral diffractive rings, which have a different optical power than the centre. Most patients experience significant reduction within 3–6 months as the brain neuroadapts — a process called cortical suppression — but some halos may persist permanently with diffractive designs.

In the majority of patients, halos are not permanent in the sense that they are consciously distressing. Published studies show that 70–90% of patients who initially report halos after cataract surgery with premium IOLs rate them as mild or absent by 6 months post-operatively, driven by neuroadaptation. However, the halos related to the inherent diffractive optics of multifocal IOLs do not physically disappear — the brain learns to suppress them below the threshold of conscious awareness. Approximately 3–5% of patients with premium diffractive IOLs experience clinically bothersome persistent halos requiring intervention (tinted lenses, pupil-modulating drops, or IOL exchange in refractory cases).

Among premium IOLs, non-diffractive EDOF IOLs produce the least halos and glare. Diffractive EDOF IOLs produce intermediate levels. Diffractive trifocal IOLs produce the highest measurable halo intensity but also offer the greatest spectacle independence. Enhanced monofocal IOLs generate halos similar to standard monofocal IOLs — very low. For patients prioritising minimal photic phenomena over spectacle independence, a non-diffractive EDOF or enhanced monofocal IOL is the evidence-based choice. IOL material also matters: hydrophilic acrylic IOLs with bevelled or rounded edges tend to produce fewer positive dysphotopsia symptoms than hydrophobic acrylic IOLs with sharp square edges.

Negative dysphotopsia is a temporal dark arc or shadow perceived in the peripheral visual field after cataract surgery. Unlike halos (positive dysphotopsia, caused by excess light), negative dysphotopsia is caused by a shadow cast by the IOL edge on the peripheral retina via total internal reflection. Reported incidence is up to 20% subjectively, though most cases resolve spontaneously within 6 months. Risk factors include small-diameter optics, high refractive index IOL material, and certain corneal incision configurations. Piggyback IOL implantation, reverse optic capture, or IOL exchange resolves refractory cases.

Most patients achieve stable, clear vision within 4–8 weeks of cataract surgery. Full neuroadaptation to premium IOLs — including the brain's suppression of halos and contrast sensitivity differences — takes 3–12 months. Patients who actively engage in near-vision tasks, who receive bilateral implantation, and who have prior spectacle or contact lens experience adapt fastest. By 12 months, approximately 88–92% of patients with trifocal IOLs are satisfied with their vision quality and would choose the same lens again.

EDOF IOLs can cause halos, but significantly fewer and less intense than diffractive trifocal IOLs. Non-diffractive EDOF platforms produce halos comparable to enhanced monofocal IOLs — typically rated as trace or mild. Diffractive EDOF designs produce moderate halos, less than trifocal but more than refractive EDOF. A 2026 three-year mix-and-match study found that trifocal + EDOF combinations produced fewer photic phenomena overall than bilateral trifocal implantation while preserving near vision independence.

Yes — the vast majority of premium IOL patients drive at night within 4–8 weeks of surgery and report improved visual quality vs. their pre-operative cataract vision. In the early weeks, halos around oncoming headlights and traffic signals may be distracting. Most studies show that night driving confidence improves progressively with neuroadaptation and is not significantly different from standard monofocal IOL patients at 6 months. Patients with large scotopic pupils (>6 mm) or who drive professionally at night should discuss EDOF vs. trifocal options carefully with their surgeon pre-operatively.

References & Evidence Base

Peer-reviewed
citations.

This article synthesises evidence from 12 peer-reviewed publications. All clinical data cited with primary source.

Vámosi P, et al. "Negative dysphotopsia in pseudophakic eyes." J Cataract Refract Surg. 2010; PMC 9188193, 2021.
Holladay JT, et al. "Negative dysphotopsia: causes and rationale for prevention and treatment." J Cataract Refract Surg. 2012;38(7):1266-85.
Davison JA. "Positive and negative dysphotopsia in patients with acrylic intraocular lenses." J Cataract Refract Surg. 2000;26(9):1346-55.
Hayashi K, et al. "Shedding Light on Halos: Quantifying the Impact of the Diffractive Profile in Multifocal IOLs." PMC 12811895. 2025.
Casprini F, et al. "Three-year comparison of two mix-and-match strategies: enhanced monofocal and trifocal vs enhanced monofocal and trifocal EDOF intraocular lenses." PMC 12928826. 2026.
Kohnen T, et al. "Comparative Outcomes of Next-Generation Extended Depth-of-Focus and Enhanced Monofocal IOL in Cataract Surgery." J Clin Med. 2025;14(14):4967.
Braga-Mele R, et al. "Multifocal intraocular lenses: relative indications and contraindications for implantation." J Cataract Refract Surg. 2014;40(2):313-22.
Cochrane Collaboration. "Comparative efficacy and safety of all kinds of IOLs in presbyopia-correcting cataract surgery: systematic review and meta-analysis." PMC 11020619. 2024.
Werner L, et al. "Edge profile of commercially available square-edged intraocular lenses." J Cataract Refract Surg. 2009;35(2):352-7.
Packer M. "The intraocular lens of the future." Curr Opin Ophthalmol. 2019.
Henderson BA, Yi DH. "Positive dysphotopsia: a literature review and reoccurrence after IOL exchange." J Cataract Refract Surg. 2011;37(7):1333-7.
EyeWiki (AAO). "Ophthalmic Viscosurgical Devices." American Academy of Ophthalmology. eyewiki.org. 2025.

Continue Reading